CYTEK BIOSCIENCES, INC.
Balance Sheet
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $177.9M | $168.8M | $167.3M | $163.6M | $131.5M | $129.5M | $296.6M | $341.5M |
| Accounts Receivable | $44.6M | $50.3M | $55.9M | $55.4M | $49.6M | $43.1M | $48.9M | $39.6M |
| Inventory | $50.1M | $54.7M | $60.9M | $66.9M | $65.7M | $69.5M | $48.2M | $49.4M |
| Total Current Assets | $384.1M | $388.6M | $392.1M | $422.3M | $424.8M | $425.6M | $454.0M | $443.9M |
| Property, Plant & Equipment | $18.1M | $18.2M | $18.4M | $17.4M | $15.6M | $15.5M | $13.7M | $7.8M |
| Goodwill | $16.2M | $16.2M | $16.2M | $16.5M | $19.1M | $19.1M | $10.1M | $10.1M |
| Intangible Assets (Excl. Goodwill) | $21.4M | $22.3M | $23.1M | $24.3M | $23.7M | $24.7M | $4.3M | $4.5M |
| Total Assets | $483.7M | $492.1M | $494.5M | $519.4M | $525.1M | $524.6M | $519.5M | $499.3M |
| Liabilities | ||||||||
| Accounts Payable | $3.2M | $3.7M | $3.0M | $4.7M | $3.1M | $5.3M | $4.8M | $5.6M |
| Total Current Liabilities | $52.4M | $55.6M | $56.2M | $58.7M | $53.6M | $56.5M | $49.0M | $41.5M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $94.6M | $99.5M | $101.4M | $103.9M | $100.9M | $101.1M | $93.9M | $82.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-45.8M | $-35.3M | $-29.2M | $-34.7M | $-28.2M | $-23.8M | $-17.0M | $-20.6M |
| Total Stockholders' Equity | $389.1M | $392.6M | $393.1M | $415.5M | $424.2M | $423.5M | $425.5M | $416.5M |